Aveo Capital Partners’s Boston Scientific BSX Stock Holding History

Aveo Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,461	Closed	-$1.02M	–	203
2024 Q4	$1.02M	Sell	11,461 -14	-0.1%	-$1.23K	0.11%	135
2024 Q3	$962K	Buy	11,475 +20	+0.2%	+$1.58K	0.1%	142
2024 Q2	$882K	Sell	11,455 -359	-3%	-$26.3K	0.1%	144
2024 Q1	$861K	Sell	11,814 -1,027	-8%	-$66K	0.09%	155
2023 Q4	$742K	Buy	12,841 +171	+1%	+$9.13K	0.09%	155
2023 Q3	$669K	Buy	12,670 +68	+0.5%	+$3.57K	0.09%	158
2023 Q2	$682K	Sell	12,602 -356	-3%	-$18.6K	0.09%	161
2023 Q1	$648K	Buy	+12,958	New	+$611K	0.09%	156

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Aveo Capital Partners's BSX Position: Q1 2025 in Review

Aveo Capital Partners sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 11,461 shares — an estimated $1.02M sold.

Aveo Capital Partners first reported a position in BSX in Q1 2023 and held it in 8 quarters. The position peaked at $1.02M in Q4 2024. 1,643 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

Aveo Capital Partners reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
Aveo Capital Partners sold 11,461 Boston Scientific shares in Q1 2025, an estimated $1.02M.
Aveo Capital Partners first reported a position in Boston Scientific in Q1 2023 and held it in 8 quarters.
Aveo Capital Partners's Boston Scientific position peaked at $1.02M in Q4 2024.
1,643 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Aveo Capital Partners's 13F filing for Q1 2025, filed 12 May 2025.